Trying to separate three different claims about LL-37: that it is the right molecule, that it is the right dose, and that it does something useful.
The comparison group matters more than the compound when the outcome is something as fuzzy as focus.
Baseline first. Without a baseline the after picture is decoration.
Anyone got a paper worth reading on this rather than a write-up of a paper?
Sleep, food, or the compound? Yes.
A plausible mechanism is not an outcome, and this class is the textbook example.
Cold storage, light protection, date on the vial. Boring, removes half the variables.
Underdosing and tolerance are indistinguishable from the inside, and everyone picks the flattering explanation.
Log dose, time and sleep. Ten seconds a day and it turns the anecdote into something you can look at.
I would take the narrow conclusion. Broad ones are more interesting and less true.
Most of what is called evidence here is one person, one vial, one month. Not on LL-37 but the pattern is familiar.
Test one thing at a time. It feels slower and it is the only way to learn anything.
Stupid question: how do you know whether what is in the vial matches the label at all?
Stupid question: how do you know whether what is in the vial matches the label at all?
Is a baseline blood test really necessary before starting something like this?
Narrow conclusion.
An inconclusive account is useful if it stops the next person mistaking a story for a controlled comparison.
Three questions kill most of the confidence in a thread like this: sample size, blinding, who paid.